Karo Bio AB

    [td_text_with_title custom_title=”Karo Bio AB”]Karo Bio is a development company with a focus on broadening its activities to cover projects and products closer to market. The company has several projects on the way to the clinical phase. Operations are conducted in Huddinge, Sweden and the share is listed on Nasdaq Stockholm.[/td_text_with_title]

    Posts not found

    [td_text_with_title custom_title=”Latest post”]

    Karo Bio AB acquires Tanomed for 20 MSEK

    Stockholm, April 10, 2015 – Karo Bio has signed an agreement to acquire the drug research company Tanomed AB, which has developed a unique product for common cold. The acquisition provides Karo Bio access to a new product to relieve and prevent progression of common cold by reinforcing the body’s own defenses to fight common […]